Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
Information for patients and caregivers about ALOXI® (palonosetron HCl).
Mar 14, 2016 ... ALOXI (palonosetron hydrochloride) is an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT3) receptor antagonist with a strong ...
Jul 5, 2017 ... Easy to read patient leaflet for palonosetron. Includes indications, proper use, special instructions, precautions, and possible side effects.
Jan 15, 2015 ... Palonosetron Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is the ...
Medscape - Antiemetic dosing for Aloxi (palonosetron), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation ...
May 6, 2010 ... This page contains brief information about palonosetron hydrochloride and a collection of links to more information about the use of this drug, ...
ALOXI. ALOXI (palonosetron HCl) Capsules Initial U.S. Approval: 2003 ... The potential for clinically significant drug interactions with palonosetron appears to be ...
administration. Each 5-ml vial of Aloxi injection contains 0.25 mg palonosetron base as hydrochloride, 207.5 mg mannitol, disodium edetate and citrate buffer in ...